CEO and co-founder of Magnus Medical. BME PhD, neurotech and data wrangler. Building stuff for your brain, stuff that works. Cyclist, climber, father of two.
San Francisco, CA
Joined February 2010
- Tweets247
- Following53
- Followers595
- Likes90
Pinned Tweet
Glad to finally share: so proud to be working with the @magnusmed team on breakthrough #neuromodulation treatment for #depression. Together we can help restore and sustain #mentalhealth.
Proud to share that the FDA granted Breakthrough Device Designation for our individualized, non-invasive, investigational #neuromodulation technology for people with major #depression. ow.ly/oE7K50GB34n
#innovation #fMRI #targeted #brainhealth
I'll withhold the sarcasm and schadenfreude, because empathy for real people who lost money. Instead I'll just share a great piece: bitchesgetriches.com/investi…
Check out the latest on SAINT - so very proud to be helping bring this technology to the world!
Very informative story on the @Todayshow featuring Dr. @NolanRyWilliams, @Stanford_BSL, talking about SAINT, a promising new, investigational treatment for major #depression. Powerful stories shared by two students treated by SAINT.
today.com/video/how-magnet-t…
Brett Wingeier retweeted
Very informative story on the @Todayshow featuring Dr. @NolanRyWilliams, @Stanford_BSL, talking about SAINT, a promising new, investigational treatment for major #depression. Powerful stories shared by two students treated by SAINT.
today.com/video/how-magnet-t…
Nice talk from @AlikWidge at @APAPsychiatric meeting just now on deep #brain stimulation in #psychiatric disease. Next gen of clinical trials should yield huge advances!
Brett Wingeier retweeted
Many thanks to @CBSSunday for a great interview. I would also like to thank the team that have worked so very hard to make SAINT a reality (@EleanorJCole, @BrandonBentzley, @Stanford_BSL). @standfordmed @Stanford @StanfordPSY
ajp.psychiatryonline.org/doi…
Depression remains the leading cause of disability worldwide, affecting almost 300 million people, half of whom can't find lasting relief from drugs or therapy. However, a new experimental treatment seems to be hopeful cbsn.ws/2ZU8OjB
Congratulations to @NolanRyWilliams and the team at @Stanford_BSL for their breakthrough work on #depression which appeared on @CBSSunday today. And honored to be part of @MagnusMed entrusted with bringing it to the world. #mentalhealth #brainhealth youtu.be/0E00FEYzR6M
Thanks, @neurotechwriter, for including @MagnusMed in the Neurotech Leaders Forum next week! Looking forward to it, and in particular spending time talking about the need and opportunities for #neuromodulation in #mentalhealth with great folks advancing #neurotech.
Brett Wingeier retweeted
The 20th Anniversary Neurotech Leaders Forum takes place next week! lnkd.in/g5S397mm
Brett Wingeier retweeted
Please RT!
Stanford BSL is hiring a full time Data Analyst 1 position. see link for more details. careersearch.stanford.edu/jo…
Well, I can't figure out a way to tweet this without dropping an ultra-high-res photo of my face into everyone's feeds. But nonetheless - thanks @SFBIZronleuty for a great piece on @magnusmed and our breakthrough #neuromodulation tech for #depression! bizjournals.com/sanfrancisco…
Brett Wingeier retweeted
#MagnusMedical announced today that it received FDA breakthrough device designation for its #Neurostimulation technology and raised $25 million.
MORE ON THIS HERE: massdevice.com/fda-grants-br…
#MDD #Depression #MentalHealth #Neuro @wingeier @mAGNUSMEDICAL @MagnusHealth
Brett Wingeier retweeted
We’ve made great strides in treating diabetes & heart disease, but the same can’t be said for illnesses of the brain—like major depression—which affects 17.3 million U.S. adults. This news about SAINT technology holds promise for so many, and couldn’t have come at a better time.
The FDA has granted Breakthrough Device Designation for our individualized, #non-invasive, investigational #neuromodulation technology for people with major #depression. More here: ow.ly/Utws50GB4mL
#fMRI #targeted #brainhealth #mentalhealth #targeted
Brett Wingeier retweeted
Excellent work from folks at Stanford. Can’t stress enough the importance of fMRI/MRI-guided individualized target localization in #TMS. This is such an interesting method — using the dlPFC location with functional connectivity most anti correlated with sgACC during rest.
Encouraging data in @APAPubJournals from our double-blinded RCT evaluating Stanford Neuromodulation Therapy (SNT) for treatment-resistant #depression. After 5 days, 79% in the active group experienced remission from depression compared to 13% in sham. ajp.psychiatryonline.org/doi…
Thanks to @ConorHale and @FierceMedTech / @FierceBiotech for your great coverage of @magnusmed's technology for treatment-resistant #depression! fiercebiotech.com/medtech/ma…
Brett Wingeier retweeted
Additionally, no severe adverse events occurred during the trial! The only side effect that approached statistical significance in the active treatment group over the sham treatment group was headache.
Brett Wingeier retweeted
Encouraging data in @APAPubJournals from our double-blinded RCT evaluating Stanford Neuromodulation Therapy (SAINT) for treatment-resistant #depression. After 5 days, 79% in the active group achieved remission from depression compared to 13% in sham
ajp.psychiatryonline.org/doi…
Great news breaking courtesy of @Gizmodo tonight - long-awaited randomized clinical trial supports remarkable effectiveness of rapid, non-invasive #neuromodulation for treatment-resistant #depression. gizmodo.com/5-day-brain-stim…
Whenever I am asked to find something in a drawer full of kids' clothes, it feels exactly like needing to find one particular snake in a drawer full of identical snakes
"Alexander von Humboldt found a dead bird in his garden and placed a blade of zinc in the beak and a shaft of silver into the rectum. An electric shock caused the bird to flap its wings and attempt to walk. He also tried the experiment on himself with unpleasant consequences."